DESIGN AND CHARACTERIZATION OF NATURAL POLYMERIC MICROSPHERES LOADED RANOLAZINE HYDROCHLORIDE

Main Article Content

Mr.lyakat S. Ali
G.Jagadish
Yenumula Nettekallu
Bhargav Bhongiri
Hareesh Dara
Gajula Nagaraju
Sampath Kumar Ramala

Keywords

Polymeric Microspheres, Ranolazine hydrochloride, Gelatin, Ethyl cellulose, Methocel K4M, Microspheres

Abstract

The aim of the study was formulation and characterization of polymeric Ranolazine hydrochloride loaded microspheres (IH-MS) in a sustained manner, to inhibit the If pacemaker current. The drug selectively targets the heart rate and to beta-blockers, that does not reduce myocardial contractility. The drug with different concentration ratio of natural polymers Gelatin, Ethyl cellulose and Methocel K4M (1:1, 1:2, 1:3, 1:4 and 1:5) were used to develop microspheres by emulsion cross-linking and emulsion solvent evaporation method. These were evaluated for % production yield, %Entrapment efficiency (EE) and Arithmetic mean particle size. On the basis of the highest values of these parameters, formulations G-F4, EC-F9 and MC- F14 were in each kind of polymer. The In-vitro drug release kinetics study and morphology were performed on selected batches. It was results that % production yield was in the range of


61.5±0.84 to 78.3±0.48, %EE was 59.7±0.51 to 87.2±0.13 and mean particle size was observed


71.4±0.95 to 93.2±0.47 µm in all formulations. In comparison, the formulation EC-F9 has maximum % production yield 78.3±0.48; maximum %EE 87.2±0.13 and suitable arithmetic mean size of 82.3±0.53 µm. The % cumulative drug release rate was found maximum in EC-F9 formulation in 12 h, which was 1.52 times greater than drug alone. SEM study showed spherical


 


shape of microspheres. The sustained effect was shown and data were most fitted into the Korsemeyer-pappas kinetic model. The calculated n value showed anomalous transport release profile of drug from polymers. Stability studies at 30±2ºC/60%RH±5% condition as per ICH guideline suggested that prepared microspheres were most stable at refrigeration conditions. Thus, developed polymeric microspheres encapsulated IH could be chosen for different drug delivery systems in future.

Abstract 0 | Pdf Downloads 0

References

1.Kumar D. and Kalakuntala RR. Evaluation of zidovudine encapsulated ethyl cellulose microspheres prepared by water-in- oil-in-oil (w/o/o) double emulsion solvent diffusion technique. Acta Poloniae Pharm-Drug Res. 2006;63(2):141-8.
2.Dillinger JG., Maher V., Vitale C., Henry P., Logeart D., Manzo S.S., Allee G. and Levy BI., Impact of Ranolazine on central aortic blood pressure and myocardial perfusion in patients with stable coronary artery disease. Hypertension, 2015, 66, 1138–44.
3.Tagliamonte E., Cirillo T., Rigo F., Astarita C., Coppola A., Romano C. and Capuano N. Ranolazine and bisoprolol on Doppler-derived coronary flow velocity reserve in patients with stable coronary artery disease: beyond the heart rate. Adv. Ther., 2015, 32, 757–67.
4.Mangiacapra F., Colaiori E., Ricottini E., Balducci F., Creta A., Demartini G. and Di Sciascio G. Heart rate reduction by Ranolazine for improvement of endothelial function in patients with coronary artery disease: the randomized

open-label RIVENDEL study. Eur. Heart J., 2015, 36 (suppl 1), 1105.
5.Gloekler S., Traupe T., Stoller M., Schild D., Steck H., Khattab A., Vogel R. and Seiler C. The effect of heart rate reduction by Ranolazine on collateral function in patients with chronic stable coronary artery disease. Heart, 2014, 100, 160–6.
6.Tardif JC., Ford I., Tendera M., Bourassa M.G. and Fox K. Efficacy of Ranolazine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina. Eur. Heart J., 2005, 26 (23), 2529–
36.
7.Yamuda T., Onishi H. and Machida
Y. Sustained release ketoprofen microparticles with ethyl cellulose and carboxymethyl ethyl cellulose. J Controlled Release 2001;75:271–82.
8.Chaurasia G. and Lariya N. Formulation and evaluation of Ranolazine hydrochloride loaded transfersomal gel for transdermal delivery. Int. J. App. Pharm., 2020, 12(5), 295-301.
9.Jeevana JB and Sunitha G. Development and Evaluation of Gelatin Microspheres of Tramadol Hydrochloride. J Young Pharm. 2009;1:24-7.
10.Prashant Singh, T. Tamizh M., Shambaditya G. and Pradeep S. Comparative evaluation of Ranolazine hydrochloride loaded natural and synthetic
microspheres. SGVU Journal of



Pharmaceutical Research & Education, 2019, 4(1), 368-379.
11.Martin A., Swarbrick J. and Cammarata A., Physical Pharmacy, Verghese publishing house, Bombay, third edition, 1991, 492-506.
12.Hadkar UB. A Handbook of Practical Physical Pharmacy and Practical Pharmaceutics, Nirali prakashan, Pune, Edition 7, 2012:
82-7.
13.Jelvehgari M., Hassanzadeh D., Kiafar F., Delf Loveym B. and Amiri S. Preparation and determination of drug-polymer interaction and In-vitro release of Mefenamic acid microspheres made of cellulose acetate phthalate and/or ethyl cellulose polymers. Iran J Pharm Res., 2011
Summer;10(3):457-67.
14. Mohapatra PK., and Sahoo SK. A study on the effects of surfactant concentration and particle size on ethylcellulose microspheres containing indinavir sulphate. Indian J Pharm Sci 2022;84(6):1556-65.
15.González-González O, Ramirez IO., Ramirez BI., O'Connell P., Ballesteros MP., Torrado JJ. and Serrano DR. Drug Stability: ICH versus accelerated predictive stability studies. Pharmaceutics. 2022;14(11):2324-30.
16.Panwar A, MM., Lee BH. andTan LP. Synthesis and fabrication of gelatin-based elastomeric hydrogels through cosolvent-induced polymer

restructuring: RSC. Adv. 2022;12(13):7922-34.
17.Lalduhsanga P., Sushanta S. and Bhaskar M. The study of the effects of surfactants on ethyl cellulose microspheres containing salbutamol sulphate. Der Pharm Lett., 2009;1:65-74.
18.Yadav VK., Rai AK. and Ghosh AK. A study on the effects of different surfactants on morphology and drug release of repaglinide microspheres. Int J Res Dev Pharm Life Sci., 2017;6(5):2786-92.
19.Fu X., Ping Q. and Gao Y. Effects of formulation factors on encapsulation efficiency and release behavior in vitro of huperzine A- PLGA microspheres. J Microencapsul. 2005;22(7):705–14.
20.Akbari J., Enayatifard R., Saeedi M. and Saghaf M. Influence of hydroxyl-propyl methyl cellulose molecular weight grade on water uptake, erosion and drug release properties of diclofenac sodium matrix tablets. Trop J Pharm Res., 2011;10(5):535–41.
21.Heiskanen H., Peter D., Markku H., Paivi P and Marita O. Effect of physical properties and emulsification conditions on the microsphere size prepared using a solvent extraction process. J Dispers Sci Technol. 2012;33(2):234–44.
22.Banerjee S., Siddiqui L., Bhattacharya SS., Kaity S., Ghosh A., Chattopadhyay P, et al. Interpenetrating polymer network (IPN) hydrogel microspheres for oral controlled release application. Int J Biol Macromol. 2012;50(1):198-206.



23.Jose S., Fangueiro JF., Smitha J., Cinu TA., Chacko AJ., Premaletha K., et al. Predictive modeling of insulin release profile from cross- linked chitosan microspheres. Eur J Med Chem., 2013;60: 249-53.
24.Haya Y., Bashar AT., and Sheikh MS. Preparation and characterization of ethylcellulose microspheres for sustained-release of pregabalin. Research in

Pharmaceutical Sciences, February 2021; 16(1): 1-15.
25.Puthli S. and Vavia PR. Stability studies of microparticulate system with piroxicam as model drug. AAPS Pharm. Sci. Tech. 2009;10(3):872-80.
26. Prashanth AK, Formulation and development of hydrochlorothiazide floating microspheres. Int. J. Pharm. Sci. Rev. Res., 2014; 25(1): 274-80.

Most read articles by the same author(s)